Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin and celecoxib for post-fracture tibial pain
IRCT20191104045328N54Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gabapentin and celecoxib in tibia fracture and postoperative pain (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Pain intensity after tibia fracture. Started May 2026; status: completed.
02
Drugs
gabapentincelecoxib
03
Conditions
tibia fracturepostoperative pain
Beyond the preview
Go deeper on IRCT20191104045328N54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N54.